Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Eurogin
 

December 4-7, 2019

Grimaldi Forum, Monaco

  • 
  • Scientific Information
    • Welcome Message
    • Message from the Chairman of the Scientific Committee
    • Program Committee
    • Program Objectives
    • Instructions For Speakers
    • Key Features And Target Audience
    • Deadlines
    • Previous Congress Presidents
    • Previous Congresses
  • Program & CME
    • Online Program
    • Final Program
    • Program Overview
    • Program Topics
    • CME Credits
    • HPV And Head & Neck Forum
    • Workshop Vulvar and anal diseases
    • Cervical Cancer Screening Quality Assurance
    • Workshop HPV Immunization
    • Colposcopy Course
    • Workshop Francophone
    • Quality of Life - Genital Restoration
  • Registration
    • Online Registration
    • Registration Information
    • Eurogin Grants
  • Abstracts & Posters
    • Abstracts 2019
    • Posters
    • Poster Information
    • Abstract Information
    • Abstract Topics
    • Eurogin Grants
  • Sponsorship And Exhibition
    • Sponsorship Information
    • Sponsor Brochure
    • Sponsors and Exhibitors
    • Ethical Compliance
    • Exhibition Floorplan
    • Exhibitor's Guide
  • Travel And Hotels
    • Travel Info
    • Hotels
  • Congress Information
    • Information For French Participants
    • Practical Information
    • Congress Venue
    • Congress App Eurogin 2019
    • Contact
    • Legal Information
Previous
Next
  • Home
  • English
  • Program & CME
  • Cervical Cancer Screening Quality Assurance

CERVICAL CANCER SCREENING QUALITY ASSURANCE

Training workshop for cervical cancer screening program coordinators and evaluators on quality assurance in cervical cancer screening (included with congress registration)

Wednesday, Dec. 4, 2019

Coordinators:
S. Lönnberg (Finland), N. Segnan (Italy)

Screening and prevention of cervical cancer is undergoing major changes with the deployment of new screening methods and immunization programmes. However, screening coverage remains an important determinant for the success of population-based cancer prevention efforts. Many programmes still struggle with suboptimal attendance or adherence to the guidelines. This workshop aims to assess the recommendations from the current European guidelines and explore available strategies to improve screening coverage among hard to reach of women, discuss barriers to implementation of the quality assured screening strategies and look for possible solutions.

13.30 - 15.00 : Part I


  • Opening - What do we mean with quality assurance and quality improvement?
    S. Lönnberg (Finland) and N. Segnan (Italy)
  • Recommended QA and organization of cervical cancer screening
    S. Lönnberg (Finland)
  • Barriers in attendance and access to quality assured screening
    D. Rezeberga (Latvia)
  • Screening and importance of primary prevention
    P. Armaroli (Italy)
  • How to enroll actively in a cohort never or inadequately screened women
    N. Segnan (Italy)
  • Implementation and findings of primary HPV testing based on screening statistics
    M. Elfström (Sweden)

15.00 - 15.30 : Coffee Break


15.30 - 17.00 : Part II - Interactive part with selection of papers


Interactive part with presentations from conference participants. Focus: resolving barriers for effective screening, e.g. on poor coverage or attendance, problems with adherence to guidelines – also in the management of women tested positive – or lack of necessary evaluation research and monitoring. Five presentations with discussion with the faculty and audience.

  • Low cervical cancer screening programme coverage – how to motivate non-attenders of different age groups?
    Dace Rezeberga (Latvia)
  • Interventional study evaluating cervical cancer screening strategies for women in precarious conditions in France
    Laura Reques (France)
  • Continuous quality monitoring leads to the identification of non-participation, irregular participation and inadequate follow-up as issues for improving effectiveness of cervical screening
    Annemie Haelens (Belgium)
  • Evaluation of cervical cancer screening uptake and risk factors knowledge: health beliefs model (HBM)
    Eeshetu Haile (Belgium)
  • Cervical cancer prevention and control program in Nepal: a success or failure?
    Sarita Ghimire (Nepal)
  • Registration

    to EUROGIN congress 2019

  • ABSTRACT SUBMISSION DEADLINE

    August 27,  2019

  • PROGRAM

    2019 program overview

  • HPV AND HEAD & NECK FORUM

SPECIALIZED WORKSHOPS
  • HPV Immunization
  • Vulvar and Anal Diseases
  • CC Screening Quality Assurance 
  • Colposcopy Course

ABOUT EUROGIN

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.

ETHICAL COMPLIANCE

TRUSTED PARTNER

EFPIA/e4ethics

Pre-assessment
img-responsive
EFPIA/e4ethics
img-responsive

USEFUL LINKS

  • EUROGIN PORTAL |
  • Previous events |
  • Legal Information

ENDORSED BY

Informa Markets

Copyright © 2020. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions